I am excited to share a preprint describing my take on extracellular targeted protein degradation (eTPD) - a proximity modality termed Sheddase-Targeting Chimeras (SHEDTACs).
www.biorxiv.org/content/10.6... 👀
I am excited to share a preprint describing my take on extracellular targeted protein degradation (eTPD) - a proximity modality termed Sheddase-Targeting Chimeras (SHEDTACs).
www.biorxiv.org/content/10.6... 👀
This was a big team effort led by
@inesforrest.bsky.social
and in collaboration with AbbVie.
I am grateful to my mentors, collaborators, friends, and family for their support throughout this challenging yet rewarding and unforgettable journey! 🧬
Excited for the next chapter! 🎓
I am grateful to my mentors, collaborators, friends, and family for their support throughout this challenging yet rewarding and unforgettable journey! 🧬
Excited for the next chapter! 🎓
I will defend my PhD Dissertaion on May15 at 14:00 PST.
Tune in to learn all about “Therpeutic Sialidase Conjugates Targeting the Glyco-Immune Axis in Cancer”.
(Link in the comments)
#Siglec #SialicAcid #Glycotime
I will defend my PhD Dissertaion on May15 at 14:00 PST.
Tune in to learn all about “Therpeutic Sialidase Conjugates Targeting the Glyco-Immune Axis in Cancer”.
(Link in the comments)
#Siglec #SialicAcid #Glycotime
www.biorxiv.org/content/10.1...
I hope everyone enjoyed our annual #CASFutureLeaders #HolidayCheerUp. I know I did. Thank you to our amazing community for another year of laughs... and learning.
I hope everyone enjoyed our annual #CASFutureLeaders #HolidayCheerUp. I know I did. Thank you to our amazing community for another year of laughs... and learning.